LoQus23 Therapeutics
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- $62M
Investors
- 3
About LoQus23 Therapeutics
Founded in 2019 in Cambridge, UK, LoQus23 Therapeutics specializes in the development of therapeutics for triplet repeat expansion diseases.LoQus23 Therapeutics specializes in the development of small molecule somatic expansion inhibitors aimed at treating Huntington’s Disease and other triplet repeat expansion diseases. The core product offerings focus on halting DNA instability, which contributes significantly to neurodegeneration. The primary end users are patients suffering from these disorders, along with healthcare providers and research institutions.50 from its collaborations in the biopharmaceutical sector. The company engages in partnerships with research institutions and healthcare providers for the development of their proprietary inhibitors. The company aims to expand its therapeutic offerings and enter new markets, particularly in North America and Europe, by 2025.
Who invested in LoQus23 Therapeutics
3 investors across 3 rounds
See all investors in LoQus23 Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LoQus23 Therapeutics
Who invested in LoQus23 Therapeutics?
LoQus23 Therapeutics has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LoQus23 Therapeutics raised?
LoQus23 Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did LoQus23 Therapeutics last raise money?
LoQus23 Therapeutics's most recent round on record is a Series A, in Oct 2024.
What does LoQus23 Therapeutics do?
Founded in 2019 in Cambridge, UK, LoQus23 Therapeutics specializes in the development of therapeutics for triplet repeat expansion diseases.
Where is LoQus23 Therapeutics headquartered?
LoQus23 Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like LoQus23 Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at LoQus23 Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like LoQus23 Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.